Table 2. Epitope sequence analysis and correlation with CD127 expression.
Pt | gt | NS3-1073 | % | CD127 | NS3-1406 | % | CD127 | NS5-2594 | % | CD127 | NS5-2841 | % | CD127 |
1 | 1b | CVNGVCWTV | 0.06 | lo | |||||||||
2 | 1b | CVNGVCWTV | 0.01 | lo | |||||||||
3 | 1b | n.a. | 0.07 | lo | |||||||||
4 | 1a | KLVALGVNAV | 0.02 | hi | ALYDVVSKL | 0.03 | lo | ||||||
6 | 1a | CINGVCWSI | 0.02 | lo | |||||||||
7 | 1a | CINGVCWTA | 0.01 | hi | |||||||||
9 | 1b | KLSGLGLNAV | 0.17 | hi | |||||||||
13 | 1b | n.a. | 0.03 | mid | |||||||||
14 | 1b | CVNGVCWTV | 0.02 | lo | |||||||||
15 | 1a | CINGVCWTV | 0.12 | lo | |||||||||
16 | 1a | CINGVCWTV | 0.05 | lo | ALYDVVSKL | 0.03 | lo | ||||||
17 | 1a | n.a. | 0.02 | lo | n.a. | 0.02 | lo | ||||||
18 | 1b | CINGVCWTV | 0.01 | lo | |||||||||
20 | 1a | CINGVCWTV | 0.01 | mid | |||||||||
21 | 1b | CINGVCWTV | 0.02 | mid | |||||||||
22 | 1b | CLNGVCWTV | 0.10 | mid | |||||||||
23 | 1b | CVNGVCWTV | 0.02 | lo | |||||||||
24 | 1b | VRMILATHF | 0.18 | hi | |||||||||
25 | 1a | CINGVCWSV | 0.03 | hi | |||||||||
26 | 1a | CINGVCWTV | 0.03 | lo | KLVALGVNAV | 0.04 | mid | ||||||
27 | 1b | VRMIMMTHF | 0.16 | hi | |||||||||
28 | 1a | CINGVCWTV | 0.04 | lo | |||||||||
29 | 1a | CINGVCWTV | 0.27 | lo | |||||||||
30 | 1b | CVNGVCWTV | 0.10 | lo | |||||||||
31 | 1b | CVSGVCWTV | 0.13 | hi | |||||||||
32 | 1b | CINGVCWTV | 0.01 | mid | KLVGLGLNAV | 0.02 | hi | ALYDVVSKL | 0.20 | hi | |||
33 | 1a | CINGVCWTA | 0.05 | hi | KLVALGINAV | 0.07 | mid | ALYDVVSKL | 0.06 | lo | |||
34 | 1a | CINGVCWTV | 0.02 | mid | |||||||||
35 | 1a | CINGVCWTV | 0.12 | lo | |||||||||
36 | 1a | CINGVCWTV | 0.01 | mid | |||||||||
37 | 1b | CVNGVCWTV | 0.03 | lo | |||||||||
38 | 1a | CINGVCWTV | 0.03 | lo | |||||||||
Con | 1a | CINGVCWTV | KLVALGINAV | ALYDVVSKL | ARMILMTHF | ||||||||
Con | 1b | CVNGVCWTV | KLSGLGLNAV | ALYDVVSTL | ARMILMTHF |
Autologous virus sequences were obtained from patients with genotype 1 with detectable HCV-specific CD8+ T cell responses targeting immunodominant epitopes. Level of CD127 on T cells recognizing these epitopes is indicated next to the tetramer frequency and the respective sequence (hi: >80% CD127 expression, mid: 50–80% CD127 expression, lo: <50% CD127 expression). The consensus sequences for genotype 1a and 1b are shown below. Differing amino acids from variant autologous sequences are highlighted in bold. Abb.: Con, consensus sequence; gt, HCV genotype; n.a., not available; Pt, patient.